Mindray Squamous Cell Carcinoma Antigen (SCCA) CLIA Reagent Kit

Mindray Squamous Cell Carcinoma Antigen (SCCA) CLIA Reagent Kit is an in vitro diagnostic chemiluminescence immunoassay for the quantitative determination of Squamous Cell Carcinoma Antigen in human serum or plasma using compatible Mindray CL-series automatic chemiluminescence immunoassay analyzers. It is intended as an aid in the management of patients with malignant tumors and is not recommended as a general population cancer-screening test. Squamous Cell Carcinoma Antigen is a tumor-associated glycoprotein that can be elevated in certain squamous cell carcinomas, including cancers involving the cervix, lung, head and neck, and esophagus. Results should be interpreted alongside clinical findings and other diagnostic investigations. Key Features - Quantitative determination of Squamous Cell Carcinoma Antigen - Commonly identified as SCCA - Uses chemiluminescence immunoassay technology - Two-site sandwich assay principle - Suitable for human serum or plasma - Compatible with Mindray CL-series CLIA analyzers - Liquid, ready-to-use reagent components - Analytical sensitivity of ≤0.1 ng/mL - Reportable range of 0.1–70 ng/mL - Extended range up to 700 ng/mL with 10-fold dilution - Requires approximately 30 µL sample per test - Available in 2 × 50 tests and 2 × 100 tests - Intended for professional in vitro diagnostic use